Europe Minimal Residual Disease Testing Market

Europe Minimal Residual Disease Testing Market Size, Share & Industry Trends Analysis Report By Application (Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors and Others), By End User, By Technology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-12928 Publication Date: December-2022 Number of Pages: 94
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Minimal Residual Disease Testing Market, by Application
1.4.2 Europe Minimal Residual Disease Testing Market, by End User
1.4.3 Europe Minimal Residual Disease Testing Market, by Technology
1.4.4 Europe Minimal Residual Disease Testing Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Minimal Residual Disease Testing Market by Application
3.1 Europe Hematological Malignancies Market by Country
3.2 Europe Leukemia Market by Country
3.3 Europe Lymphoma Market by Country
3.4 Europe Solid Tumors Market by Country
3.5 Europe Others Market by Country

Chapter 4. Europe Minimal Residual Disease Testing Market by End User
4.1 Europe Hospitals & Specialty Clinics Market by Country
4.2 Europe Diagnostic Laboratories Market by Country
4.3 Europe Academic & Research Institutes Market by Country
4.4 Europe Others Market by Country

Chapter 5. Europe Minimal Residual Disease Testing Market by Technology
5.1 Europe Polymerase Chain Reaction (PCR) Market by Country
5.2 Europe Next-Generation Sequencing (NGS) Market by Country
5.3 Europe Flow Cytometry Market by Country
5.4 Europe Others Market by Country

Chapter 6. Europe Minimal Residual Disease Testing Market by Country
6.1 Germany Minimal Residual Disease Testing Market
6.1.1 Germany Minimal Residual Disease Testing Market by Application
6.1.2 Germany Minimal Residual Disease Testing Market by End User
6.1.3 Germany Minimal Residual Disease Testing Market by Technology
6.2 UK Minimal Residual Disease Testing Market
6.2.1 UK Minimal Residual Disease Testing Market by Application
6.2.2 UK Minimal Residual Disease Testing Market by End User
6.2.3 UK Minimal Residual Disease Testing Market by Technology
6.3 France Minimal Residual Disease Testing Market
6.3.1 France Minimal Residual Disease Testing Market by Application
6.3.2 France Minimal Residual Disease Testing Market by End User
6.3.3 France Minimal Residual Disease Testing Market by Technology
6.4 Russia Minimal Residual Disease Testing Market
6.4.1 Russia Minimal Residual Disease Testing Market by Application
6.4.2 Russia Minimal Residual Disease Testing Market by End User
6.4.3 Russia Minimal Residual Disease Testing Market by Technology
6.5 Spain Minimal Residual Disease Testing Market
6.5.1 Spain Minimal Residual Disease Testing Market by Application
6.5.2 Spain Minimal Residual Disease Testing Market by End User
6.5.3 Spain Minimal Residual Disease Testing Market by Technology
6.6 Italy Minimal Residual Disease Testing Market
6.6.1 Italy Minimal Residual Disease Testing Market by Application
6.6.2 Italy Minimal Residual Disease Testing Market by End User
6.6.3 Italy Minimal Residual Disease Testing Market by Technology
6.7 Rest of Europe Minimal Residual Disease Testing Market
6.7.1 Rest of Europe Minimal Residual Disease Testing Market by Application
6.7.2 Rest of Europe Minimal Residual Disease Testing Market by End User
6.7.3 Rest of Europe Minimal Residual Disease Testing Market by Technology

Chapter 7. Company Profiles
7.1 Bio-Rad Laboratories, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.2 Guardant Health, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.3 Invitae Corporation (ArcherDX, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Bio-Techne Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trails:
7.6 ICON plc (MolecularMD Corporation)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 Natera Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Laboratory Corporation of America Holdings
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Partnerships, Collaborations, and Agreements:
7.9.4.2 Product Launches and Product Expansions:
7.10. Invivoscribe, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo